Baxter To Distribute Ceprate During Cellpro Bankruptcy Until Isolex Approval
This article was originally published in The Gray Sheet
Executive Summary
Baxter will distribute Cellpro's Ceprate stem cell concentration system worldwide pending approval of Nexell's Isolex stem cell collection system under a bankruptcy plan for CellPro.